Skip to main content

Table 1 Patient and disease characteristics

From: Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

  Experimental group N = 14 Control group N = 88
Age (median) 66.5 years (range 47–75 years) 59 years (range 26–76)
Gender Female 42.9% Female 51.8%
Male 57.1% Male 48.2%
BMI (median) 26.4 (range 20.31–35.08) 23.7 (range 11.47–40.04)
Origin of peritoneal carcinomatosis Colorectal 14 Colorectal 110
  1. BMI body mass index